During the development of cancers, the regulation of YAP/TAZ by the Hippo pathway is abnormal due to the modulation of the upstream kinases such as LATS1/2 and MST1/2, resulting in hypophosphorylation of YAP/TAZ and its enrichment in the nucleus (Moroishi et al., 2015). This evidence concerns the gene YAP1 and cancer.